StockCall.com Provides Stock Research on ZIOPHARM Oncology Inc., MannKind Corp., Ariad Pharmaceuticals Inc., Galena Biopharma Inc., and Novavax Inc.
New York City, New York -- (May 29, 2013)
The U.S. biotechnology sector is likely to see a sharp rise in costs as President Obama’s Affordable Care Act (ACA) goes into full effect by 2014. However, biotechnology companies, which are facing increasing competition from generic drug makers due to expiration of patents on several blockbuster drugs, are likely to benefit from the ACA in the longer-term due to the increase in the number of insured individuals. Therefore, it is not surprising that despite the costs, the U.S. healthcare sector in general has welcomed the ACA. On Tuesday, May 28, 2013, shares in biotechnology companies ended mostly higher, tracking gains in the broad market, which rallied as investors cheered some robust U.S. economic data. The major movers in the sector included ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), MannKind Corporation (NASDAQ: MNKD), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), Galena Biopharma Inc. (NASDAQ: GALE), and Novavax Inc. (NASDAQ: NVAX). StockCall has released free charting and technical research on these aforementioned companies. Register to read these reports at
Shares in ZIOPHARM Oncology Inc. fell sharply on Tuesday even as the broader market rallied. The stock closed 4.24% lower at $2.51 after trading between $2.26 and $2.51. A total of 3.42 million shares were traded which is well above the daily average volume of 1.46 million. However, despite the sharp pullback yesterday, the company’s shares have gained nearly 46.80% in the last three sessions. Sign up for the free report on ZIOP at
MannKind Corporation’s stock was one of the best performers in the biotechnology sector yesterday, closing 2.75% higher at $6.73. A total of 8.65 million shares were traded which is well above the daily average volume of 6.71 million. The company’s shares have now gained over 8% in the last three sessions. The stock is currently trading close to its 52-week high of $6.99. MNKD free technical report can be accessed by signing up at
Shares in Ariad Pharmaceuticals Inc. moved higher on Tuesday, extending their gains from previous trading sessions. The stock closed 1.02% higher at $19.77 after trading between $19.58 and $20.32. A total of 2.58 million shares were traded which is below the daily average volume of 3.21 million. The company’s shares have gained nearly 7.30% in the last three sessions. The stock has also crossed above its 50-day moving average recently. Free report on ARIA can be accessed by registering at
Galena Biopharma Inc.’s stock slipped yesterday, closing 1.95% lower at $2.51 after trading between $2.42 and $2.52. A total of 2.04 million shares were traded which is below the daily average volume of 2.35 million. The company’s shares have gained over 64% so far in 2013, outperforming the S&P 500. However, despite the huge gains this year, the stock is trading over 16.30% below its 52-week high.Register withStockCall and download the research on GALE for free at
Shares in Novavax Inc. fluctuated between gains and losses on Tuesday before finishing the day flat at $2.02. A total of 893,138 shares were traded which is well below the daily average volume of 1.45 million. The company’s shares have fallen nearly 1.50% in the last three trading sessions. The stock currently faces resistance at around $2.10. Read the full free research on NVAX by signing up to StockCall at
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
William T. Knight
Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)
Leave a comment...